Did you know that Medicare is issuing new Medical ID cards to all beneficiaries starting on April 1, 2018? For those of you who are Medicare beneficiaries or caregivers of a Medicare beneficiary, you will find the following information helpful in preparation for the transition to new Medicare cards.
Get the latest news, updates, and tricks from the Lingraphica team. Our clinical, reimbursement, and marketing teams will bring you the most up-to-date information about aphasia, speech therapy, stroke rehabilitation, and communication disorders. Check back often for new content!
Lingraphica is pleased to announce that we have earned The Joint Commission’s Gold Seal of Approval®, by demonstrating continuous compliance with The Joint Commission’s performance standards. The Gold Seal of Approval® is a symbol of quality that reflects an organization’s commitment to providing safe and effective care.
March is officially brain injury awareness month. This blog post highlights various brain injury facts and also offers resources to anyone who is suffering from this condition.
Today is the first day of Aphasia Awareness Month! We're excited to partner with two non-profit organizations supporting aphasia, AphasiaAccess and the National Aphasia Association, for a special advocacy campaign called: "Finding Words." The campaign aims to raise awareness of aphasia by collecting user-generated stories with the prompt, what one word would you use to describe aphasia and why? Lingraphica and its partners are encouraging all individuals touched by aphasia to submit their answers to this question.
This week, several members of our team are joining hundreds of thought leaders, speech-language pathologists, and aphasia advocates in Boston for the first inaugural AphasiaAccess Leadership Summit.
Our #saveSGDtech advocacy worked! Earlier in the month we received news that The Centers for Medicare and Medicaid Services (CMS) is rescinding the policies from the February Durable Medical Equipment (DME) contractors' "coverage reminder" that required speech-generating devices (SGDs) to undergo changes and reclassification. CMS also announced it is opening up the National Coverage Determination (NCD) for a 30-day comment period ending December 6, 2014. This decision comes after months of conversations with CMS and the other manufactures of SGDs about the features and functionality that SGD users need to communicate effectively in their daily lives.
The speech community is buzzing with information about changes to Medicare’s coverage for speech-generating devices (SGDs). Headlines indicate that Medicare wants to limit coverage for individuals with ALS, also known as amyotrophic lateral sclerosis, while other articles point to limits on functionality of SGDs. What the headlines miss are the stories of thousands of people with aphasia who rely on SGDs and their advanced technology to communicate.
Last week, former New Orleans Saints football player, Steve Gleason penned an op-ed inThe Washington Post about his journey with ALS. Gleason, who was diagnosed with Lou Gehrig’s disease in 2011, shares how he relies on a speech-generating device and other forms of technology to help him communicate, eat, breath, and interact with his family.
Did you know that more than two million people have aphasia in the United States? Even though a large number have the disorder, many people don’t even know about it. This June we’re hoping to change that with our Faces of Aphasia campaign -- which kicks off today.